These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26131068)

  • 1. Efficacy of growth hormone supplementation with gonadotrophins in vitro fertilization for poor ovarian responders: an updated meta-analysis.
    Yu X; Ruan J; He LP; Hu W; Xu Q; Tang J; Jiang J; Han J; Peng YF
    Int J Clin Exp Med; 2015; 8(4):4954-67. PubMed ID: 26131068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis.
    Zhang Y; Zhang C; Shu J; Guo J; Chang HM; Leung PCK; Sheng JZ; Huang H
    Hum Reprod Update; 2020 Feb; 26(2):247-263. PubMed ID: 32045470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials.
    Yang P; Wu R; Zhang H
    Reprod Biol Endocrinol; 2020 Jul; 18(1):76. PubMed ID: 32727608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
    Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
    Youssef MA; Abou-Setta AM; Lam WS
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis.
    Kolibianakis EM; Venetis CA; Diedrich K; Tarlatzis BC; Griesinger G
    Hum Reprod Update; 2009; 15(6):613-22. PubMed ID: 19561136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Dehydroepiandrosterone (DHEA) Supplementation on IVF or ICSI: A Meta-Analysis of Randomized Controlled Trials.
    Xu L; Hu C; Liu Q; Li Y
    Geburtshilfe Frauenheilkd; 2019 Jul; 79(7):705-712. PubMed ID: 31303658
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.
    Ma S; Ma R; Xia T; Afnan M; Song X; Xu F; Hao G; Zhu F; Han J; Zhao Z
    Trials; 2018 Feb; 19(1):124. PubMed ID: 29458401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
    Youssef MA; Al-Inany HG; Aboulghar M; Mansour R; Abou-Setta AM
    Cochrane Database Syst Rev; 2011 Apr; (4):CD003719. PubMed ID: 21491386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.
    Zhang M; Niu W; Wang Y; Xu J; Bao X; Wang L; Du L; Sun Y
    J Assist Reprod Genet; 2016 Aug; 33(8):981-91. PubMed ID: 27094195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
    Siristatidis CS; Vrachnis N; Creatsa M; Maheshwari A; Bhattacharya S
    Cochrane Database Syst Rev; 2013 Oct; (10):CD006606. PubMed ID: 24101529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
    Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
    Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
    Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.